BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21960365)

  • 1. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.
    Narayan G; Xie D; Freddy AJ; Ishdorj G; Do C; Satwani P; Liyanage H; Clark L; Kisselev S; Nandula SV; Scotto L; Alobeid B; Savage D; Tycko B; O'Connor OA; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1030-41. PubMed ID: 23929756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.
    Li Z; Li W; Xie J; Wang Y; Tang A; Li X; Ye J; Gui Y; Cai Z
    Cell Biol Int; 2011 Jul; 35(7):671-6. PubMed ID: 21314642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
    Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
    Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
    Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
    Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
    Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
    Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
    Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia].
    Zemliakova VV; Strel'nikov VV; Zborovskaia IB; Balukova OV; Maĭorova OA; Vasil'ev EV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2004; 38(6):966-72. PubMed ID: 15612580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
    Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
    Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the methylation of p15 gene CpG islands in acute leukemia: using methylation-specific PCR method].
    Zhang Y; Lou F; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):628-30. PubMed ID: 11721363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.